Dichloralphenazone is a controlled substance listed under DEA Schedule IV, indicating a low potential for abuse relative to Schedule III substances. It is a 1:2 compound of antipyrine with chloral hydrate, used as an active pharmaceutical ingredient in manufacturing.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Dichloralphenazone?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Antipyrine
pharmaceutical raw material
Acacetin
pharmaceutical raw material
Anthramycin
pharmaceutical raw material
Edoxaban
pharmaceutical raw material
Edoxaban tosylate
pharmaceutical raw material
Metamizole magnesium
pharmaceutical raw material
Metamizole sodium
pharmaceutical raw material
2-(2,4-Dimethylphenyl)-1,2-dihydro-3H-pyrazol-3-one
research compound
1,5-dimethyl-2-phenylpyrazol-3-one;bis(2,2,2-trichloroethane-1,1-diol)
ATKXDQOHNICLQW-UHFFFAOYSA-N
CC1=CC(=O)N(N1C)C2=CC=CC=C2.C(C(Cl)(Cl)Cl)(O)O.C(C(Cl)(Cl)Cl)(O)O
Sourcing Dichloralphenazone?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.